External Validation of the 2003 Leibovich Prognostic Score in Patients Randomly Assigned to SORCE, an International Phase III Trial of Adjuvant Sorafenib in Renal Cell Cancer

The 2003 Leibovich score guides prognostication and selection to adjuvant clinical trials for patients with locally advanced renal cell carcinoma (RCC) after nephrectomy. We provide a robust external validation of the 2003 Leibovich score using contemporary data from SORCE, an international, randomi...

Descripción completa

Detalles Bibliográficos
Autores principales: Oza, Bhavna, Eisen, Tim, Frangou, Eleni, Stewart, Grant D., Bex, Axel, Ritchie, Alastair W.S., Kaplan, Rick, Smith, Benjamin, Davis, Ian D., Stockler, Martin R., Albiges, Laurence, Escudier, Bernard, Larkin, James, Joniau, Steven, Hancock, Barry, Hermann, Gregers G., Bellmunt, Joaquim, Parmar, Mahesh K.B., Royston, Patrick, Meade, Angela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2022
Materias:
ORIGINAL REPORTS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9148696/
https://www.ncbi.nlm.nih.gov/pubmed/35213214
http://dx.doi.org/10.1200/JCO.21.01090

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9148696/
https://www.ncbi.nlm.nih.gov/pubmed/35213214
http://dx.doi.org/10.1200/JCO.21.01090

Ejemplares similares